GlassScriptPhysician profile
Lance A Wiebusch
NPI 1154442507
$13,201.98
in general payments reported to CMS, 2019-2025
16 companies · $1,695 in 2025
The $1,695 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,397 · 2020: $814 · 2021: $111 · 2022: $66.22 · 2023: $2,915 · 2024: $204 · 2025: $1,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,877 · Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,877.16 |
| Food and Beverage | $936.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $5,959.89 | 2019 | |
| Coloplast Corp | $5,601.91 | 2019-2025 | Titan, Speedicath |
| Valencia Technologies Corporation | $990.78 | 2023 | Ecoin Device Kit |
| Pfizer INC. | $128.06 | 2019-2020 | |
| Abbvie INC. | $115.66 | 2021-2025 | Botox |
| Medtronic USA, INC. | $75.44 | 2020 | |
| Isoray, INC | $49.94 | 2022-2023 | Brachytherapy Source |
| Neotract INC. | $47.05 | 2019 | |
| Boston Scientific Corporation | $44.61 | 2019-2025 | Spaceoar Vue System - 10ml |
| Endo Pharmaceuticals INC. | $42.29 | 2021-2023 | Aveed, Xiaflex |
| Medtronic, INC. | $38.21 | 2024 | Interstim |
| Davol INC. | $34.36 | 2020 | |
| Urogen Pharma, INC. | $28.65 | 2025 | |
| Rochester Medical Corporation | $17.25 | 2020 | |
| Alnylam Pharmaceuticals INC. | $15.08 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$200,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Wiebusch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.